Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 0 | 0 | 1,404 | 0 | 0 |
| Gross Profit | N/A | N/A | 1,404 | N/A | N/A |
| Operating Expenses | 751 | 724 | 1,107 | 1,905 | 1,596 |
| Operating Income | -751 | -724 | 297 | -1,905 | -1,596 |
| Other Income | 25 | 32 | 32 | 47 | 37 |
| Pre-tax Income | -726 | -692 | 329 | -1,858 | -1,559 |
| Net Income Continuous | -726 | -692 | 329 | -1,858 | -1,559 |
| Minority Interests | -17 | -9 | -6 | -6 | -15 |
| Net Income | $-709 | $-683 | $335 | $-1,852 | $-1,544 |
| EPS Basic Total Ops | -0.21 | -0.21 | 0.11 | -0.62 | 7.96 |
| EPS Basic Continuous Ops | -0.20 | -0.22 | 0.10 | -0.63 | 3.05 |
| EPS Diluted Total Ops | -0.21 | -0.21 | 0.11 | -0.62 | 7.96 |
| EPS Diluted Continuous Ops | -0.20 | -0.22 | 0.10 | -0.63 | 3.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.21 | 0.11 | -0.62 | 1.48 |
| EBITDA(a) | $-751 | $-724 | $297 | $-1,905 | $-1,596 |